About ExpressionEdits
ExpressionEdits is a company based in Cambridge (United States) founded in 2021 by Allan Bradley, Liliana Antunes, and Kart Tomberg.. ExpressionEdits has raised $13 million across 1 funding round from investors including Octopus Ventures, Redalpine and BlueYard Capital. The company has 10 employees as of December 31, 2023. ExpressionEdits offers products and services including Genetic Syntax Engine and Intronization Technology. ExpressionEdits operates in a competitive market with competitors including DNAnexus, Cytel, Metagenomi, Octant and Kinomica, among others.
- Headquarter Cambridge, United States
- Employees 10 as on 31 Dec, 2023
- Founders Allan Bradley, Liliana Antunes, Kart Tomberg
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Expressionedits Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13 M (USD)
in 1 rounds
-
Latest Funding Round
$13 M (USD), Seed
May 29, 2024
-
Investors
Octopus Ventures
& 6 more
-
Employee Count
10
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ExpressionEdits
ExpressionEdits offers a comprehensive portfolio of products and services, including Genetic Syntax Engine and Intronization Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool that optimizes genetic designs for better protein expression in therapies.
Method to integrate introns for improved gene expression without size constraints.
Unlock access to complete
Funding Insights of ExpressionEdits
ExpressionEdits has successfully raised a total of $13M through 1 strategic funding round. The most recent funding activity was a Seed round of $13 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $13.0M
-
First Round
First Round
(29 May 2024)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Seed - ExpressionEdits | Valuation | Octopus Ventures , Redalpine |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ExpressionEdits
ExpressionEdits has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Octopus Ventures, Redalpine and BlueYard Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and support for founders in technology and health sectors.
|
Founded Year | Domain | Location | |
|
Early-stage investments are directed toward ICT and health tech startups.
|
Founded Year | Domain | Location | |
|
BlueYard Capital is engaged in early-stage technology investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ExpressionEdits
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ExpressionEdits
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Expressionedits Comparisons
Competitors of ExpressionEdits
ExpressionEdits operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Cytel, Metagenomi, Octant and Kinomica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| domain | founded_year | HQ Location |
Human cell interaction platform is provided for drug discovery.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform for precision medicine development is offered.
|
|
| domain | founded_year | HQ Location |
AI-based tools for drug discovery are provided to researchers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Expressionedits
Frequently Asked Questions about ExpressionEdits
When was ExpressionEdits founded?
ExpressionEdits was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Where is ExpressionEdits located?
ExpressionEdits is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of ExpressionEdits?
Kart Tomberg is the current CEO of ExpressionEdits. They have also founded this company.
Is ExpressionEdits a funded company?
ExpressionEdits is a funded company, having raised a total of $13M across 1 funding round to date. The company's 1st funding round was a Seed of $13M, raised on May 29, 2024.
How many employees does ExpressionEdits have?
As of Dec 31, 2023, the latest employee count at ExpressionEdits is 10.
What does ExpressionEdits do?
ExpressionEdits was founded in 2021 in Cambridge, United States, by co-founders Allan Bradley, Liliana Antunes, and Kart Tomberg, who serves as CEO. Operations are focused on the biotechnology sector, where protein expression platform development services are delivered. These services support advancements in protein engineering and related research applications. The company maintains its headquarters in the specified location to serve clients in the life sciences industry.
Who are the top competitors of ExpressionEdits?
ExpressionEdits's top competitors include DNAnexus, Cytel and Relation Therapeutics.
What products or services does ExpressionEdits offer?
ExpressionEdits offers Genetic Syntax Engine and Intronization Technology.
Who are ExpressionEdits's investors?
ExpressionEdits has 7 investors. Key investors include Octopus Ventures, Redalpine, BlueYard Capital, Wilbe, and Acequia Capital.